Growth Attenuation Therapy: Ongoing Ethical and Practical Challenges 20 Years Post Ashley
Stephen D. Brown(Boston Children's Hospital), Jonathan M. Marron(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Brian D. Snyder(Boston Children's Hospital), Faye Holder-Niles(Boston Children's Hospital), Kerri O. Kennedy(Boston Children's Hospital), Gal Kober(Bridgewater State University), Irina A. Anselm(Boston Children's Hospital), Ingrid A. Holm(Boston Children's Hospital), Margaret F. Kirber(Boston Children's Hospital), David R. Fogelman(Boston Children's Hospital)
Cited by 8
Related Papers
Recommendations for returning genomic incidental findings? We need to talk!
|Genetics in Medicine|2013|288
Pediatric Oncology Provider Views on Performing a Biopsy of Solid Tumors in Children with Relapsed or Refractory Disease for the Purpose of Genomic Profiling
|Annals of Surgical Oncology|2016|23
Why Irrigate for the Same Contamination Rate: Wound Contamination in Pediatric Spinal Surgery Using Betadine Versus Saline
|Journal of Pediatric Orthopaedics|2020|13
Pediatric Ethics Consultation: Practical Considerations for the Clinical Ethics Consultant
|The Journal of Clinical Ethics|2019|6
The Complicated Legacy of Cassandra Callender
|JAMA Pediatrics|2020|5